Metabolic syndrome and chronic kidney disease in an adult Korean population: Results from the Korean National Health Screening

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kang, Yong Un ^a   Kim, Ha Yeon ^a   Choi, Joon Seok ^a   Kim, Chang Seong ^a   Bae, Eun Hui ^a   Ma, Seong Kwon ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; ASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KOREAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PROTEINURIA; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84900538508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093795     Document Type: Article

References (38)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
2. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination survey. JAMA 287: 356-359. (Pubitemid 34251969)
3. Park HS, Oh SW, Cho SI, Choi WH, Kim YS (2004) The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 33: 328-336. (Pubitemid 38578831)
4. Chang IH, Han JH, Myung SC, Kwak KW, Kim TH, et al. (2009) Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology 14: 321-326.
5. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, et al. (2007) Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from kidney disease improving global outcomes. Kidney Int 72: 247-259. (Pubitemid 47172384)
6. Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449. (Pubitemid 39281399)
7. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, et al. (2007) Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 16: 362-367. (Pubitemid 46750768)
8. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174.
9. Lucove J, Vupputuri S, Heiss G, North K, Russell M (2008) Metabolic syndrome and the development of CKD in American Indians: The Strong Heart Study. Am J Kidney Dis 51: 21-28. (Pubitemid 350296515)
10. Luk AO, So WY, Ma RC, Kong AP, Ozaki R, et al Hong Kong Diabetes Registry. (2008) Metabolic syndrome predicts new onset of chronic kidney disease in 5829 patients with type 2 diabetes. Diabetes Care 31: 2357-2361.
11. Athyros VG, Karagiannis A, Ganotakis ES, Paletas K, Nicolaou V, et al; Assessing The Treatment Effect in Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group. (2011) Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 27: 1659-1668.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
14. National Kidney Foundation (2002) K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 (Suppl 1): S1-S266.
15. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140. (Pubitemid 41716445)
16. Palaniappan L, Carnethon M, Fortmann SP (2003) Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16: 952-958. (Pubitemid 37315495)
17. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, et al. (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373.
18. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, et al. (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741. (Pubitemid 36401550)
19. Bagby SP (2004) Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 15: 2775-2791.
20. Schelling JR, Sedor JR (2004) The metabolic syndrome as a risk factor for chronic kidney disease: More than a fat chance? J Am Soc Nephrol 15: 2773-2774. (Pubitemid 41103386)
21. Wisse BE (2004) The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15: 2792-2800.
22. Kopple JD, Feroze U (2011) The effect of obesity on chronic kidney disease. J Ren Nutr 21: 66-71.
23. Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, et al. (2007) Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71: 816-821. (Pubitemid 46624026)
24. Rashidi A, Ghanbarian A, Azizi F (2007) Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2: 976-983.
25. Sun F, Tao Q, Zhan S (2010) Metabolic syndrome and the development of chronic kidney disease among 118,924 non-diabetic Taiwanese in a retrospective cohort. Nephrology 15: 84-92.
26. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, et al. (2002) Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 62: 1743-1749. (Pubitemid 35286282)
27. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study. Kidney Int 58: 293-301. (Pubitemid 30429874)
28. Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, et al. (2009) Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 53: 59-69.
29. Cases A, Coll E (2005) Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int 68: S87-93.
30. Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, et al. (2000) Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11: 669-683. (Pubitemid 30171876)
31. Gluba A, Rysz J, Banach M (2010) Statins in patients with chronic kidney disease: why, who and when? Expert Opin Pharmacother 11: 2665-2674.
32. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, et al. (2007) Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 49: 40-74.
33. Deedwania P (2011) Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating b-blockers. J Clin Hypertens (Greenwich) 13: 52-59.
34. Banach M, Rysz J (2010) Current problems in hypertension and nephrology. Expert Opin Pharmacother 11: 2575-2578.
35. Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, et al. (2007) The metabolic syndrome and chronic kidney disease in a southeast Asian cohort. Kidney Int 71: 693-700. (Pubitemid 46494568)
36. Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, et al. (2010) Metabolic syndrome and risk of development of chronic kidney disease: The Niigata Preventive Medicine Study. Diabetes Metab Res Rev 26: 26-32.
37. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375: 181-183.
38. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: An analysis from the Whitehall II Study. Lancet 373: 2215-2221.